Historical return extremes for Alnylam Pharmaceuticals (ALNY) from 2004 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +12,336% | $3.95 | $491.22 | $124,359.49 | ||
| Max drawdownMore info about Max drawdown | -83.58% | $36.55 | $6 | $164.16 | ||
| Return since IPOMore info about Return since IPO | +3,941% | $7 | $282.85 | $40,407.14 |
- Max profitMore info about Max profit+12,336%$124,359.49
- Max drawdownMore info about Max drawdown-83.58%$164.16
- Return since IPOMore info about Return since IPO+3,941%$40,407.14
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Alnylam Pharmaceuticals (ALNY). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Alnylam Pharmaceuticals (ALNY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return